GNAS mutations at locus 201 were found in 66% of intraductal papillary mucinous neoplasms. Investigators claim mutations in a gene known as GNAS can help distinguish between nonmalignant pancreatic ...

A research team at Duke Health has identified a set of biomarkers that could help to distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. The team carried out ...

Detection of early-stage pancreatic ductal adenocarcinoma (PDAC): Sensitivity, specificity, and discriminatory properties of the serum-based PAM4-immunoassay. The effect of vascular reconstruction on ...

An international, UCSF-led research team reveal has outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. Pictured ...

A research team has identified a set of biomarkers that could help distinguish whether cysts on the pancreas are likely to develop into cancer or remain benign. A research team at Duke Health has ...

Researchers have outlined the comprehensive immune landscape and microbiome of pancreatic cysts as they progress from benign cysts to pancreatic cancer. The findings could reveal the mechanism of ...

The study also included measurement of four protein markers present in the cyst fluid. All four proteins were overexpressed in the high-risk versus the low-risk group (P < .001). Adding the findings ...

Ex vivo expansion of CTCs in culture isolated by size from patients with melanoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...

Asuragen reports data from a study of microRNA biomarkers in pancreatic cyst fluid at the American Pancreatic Association Annual Meeting Austin, Texas - November 3, 2011. Asuragen, Inc. announced ...